Diabetes drug shows promise in reducing Alzheimer's disease in an experimental model

Source :: Diabetes Week. April 7, 2014, 127
Publication Year :: 2014
Abstract: By a News Reporter-Staff News Editor at Diabetes Week -- (Boston) Researchers from Boston University School of Medicine (BUSM) have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a [...]

Subjects :: Diabetes therapy -- Analysis
Alzheimer's disease -- Drug therapy -- Research -- Analysis
Diabetes -- Research -- Drug therapy -- Analysis
Hypoglycemic agents -- Research -- Analysis
Peptides -- Analysis
Health
Boston University. School of Medicine

Tools